Positron emission tomography shows reduced striatal dopamine D1 but not D2 receptors in juvenile neuronal ceroid lipofuscinosis

Neuropediatrics

Volumn 33, Issue 3, 2002, Pages 138-141

  Rinne, Juha O ^a   Ruottinen, H M ^a   Nagren K ^a   Aberg L E ^a   Santavuori, P ^a  

^a TURKU PET CENTRE   (Finland)

Author keywords

D1, D2, Dopamine; JNCL; Neuronal Ceroid Lipofuscinosis; PET, Positron Emission Tomography; Receptors

Indexed keywords

8 CHLORO 5 (2,3 DIHYDROBENZOFURAN 7 YL) 2,3,4,5 TETRAHYDRO 3 METHYL 1H 3 BENZAZEPIN 7 OL; CARBON 11; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; RACLOPRIDE;

ADOLESCENT; ADULT; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; NEURONAL CEROID LIPOFUSCINOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RADIOCHEMISTRY; RECEPTOR DENSITY; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; CORPUS STRIATUM; FEMALE; HUMANS; MALE; NEURONAL CEROID-LIPOFUSCINOSES; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036347984     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-33677     Document Type: Article

References (25)

1. 11C]NNC 756
2. MRI of neuronal ceroid lipofuscinosis. 1I. Postmortem MRI and histopathological study of the brain in 16 cases of neuronal ceroid lipofuscinosis of juvenile or late infantile type
3. MRI of neuronal ceroid lipofuscinosis, I. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis
4. 11C]raclopride is altered by drugs that modify synaptic dopamine levels
5. Neuronal ceroid-lipofuscinosis: Preferential metabolic alterations in thalamus and posterior association cortex demonstrated by PET
6. Anatomy of the basal ganglia
7. Batten disease (Spielmeyer-Vogt; juvenile onset neuronal ceroid lipofuscinosis) maps to human chromosome 16
8. A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding
9. CLN3, juvenile NCL
10. PET shows that dopamine D1 and D2 receptors are differentially affected in AD
11. Molecular characteristics of mammalian dopamine receptors
12. PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756
13. Distribution volume ratios without blood sampling from graphical analysis of PET data
14. Dopamine receptors: From structure to function
15. 11C]methyl triflate
16. Spielmeyer-Vogt (Batten, Spielmeyer-Sjögren) disease. Distinctive patterns of cerebral glucose utilization
17. 11C]raclopride
18. 18F]fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosis
19. Neuronal ceroid lipofuscinoses in childhood
20. A variant of Jansky-Bielschowsky disease
21. 3H]raclopride: Implications for positron emission tomography of the human brain
22. 3H]raclopride binding in the rat brain
23. The neuronal ceroid-lipofuscinoses (Batten-Vogt syndrome)
24. Decreased striatal dopamine transporter density in JNCL patients with Parkinsonian symptoms
25. A favorable response to antiparkinsonian treatment in juvenile neuronal ceroid lipofuscinosis